MedTech Accelerator – Supporting MedTech Translation
The MedTech Accelerator supports Imperial researchers developing medical technologies with strong clinical and commercial potential. Our team works closely with project leads to guide technologies from early research toward clinical validation and real-world adoption.
We support translational MedTech projects by providing:
-
Translational project management aligned to Technology Readiness Levels (TRLs)
-
Quality Assurance and Regulatory Affairs (QARA) support, including regulatory strategy and quality systems
-
Strategic guidance on clinical and commercial development pathways
-
Access to Imperial’s clinical collaborators and NHS partners
-
Support to secure follow-on funding, licensing, or spin-out opportunities
Successful translation requires more than strong science. Projects must address a clear clinical need, demonstrate a credible route to market, and follow a realistic regulatory pathway. The MedTech Accelerator helps teams navigate these challenges and progress technologies toward clinical use and patient impact.
